Nicholson RI - Search Results

1

Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancer.

Kenny FS, Hui R, Musgrove EA, Gee JM, Blamey RW, Nicholson RI, Sutherland RL, Robertson JF. Kenny FS, et al. Among authors: nicholson ri. Clin Cancer Res. 1999 Aug;5(8):2069-76. Clin Cancer Res. 1999. PMID: 10473088

2

The effects of gefitinib in tamoxifen-resistant and hormone-insensitive breast cancer: a phase II study.

Gutteridge E, Agrawal A, Nicholson R, Cheung KL, Robertson J, Gee J. Gutteridge E, et al. Int J Cancer. 2010 Apr 15;126(8):1806-1816. doi: 10.1002/ijc.24884. Int J Cancer. 2010. PMID: 19739079 Clinical Trial.

3

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: nicholson ri. J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17. J Clin Oncol. 2007. PMID: 17876012

4

Biological effects of fulvestrant on estrogen receptor positive human breast cancer: short, medium and long-term effects based on sequential biopsies.

Agrawal A, Robertson JF, Cheung KL, Gutteridge E, Ellis IO, Nicholson RI, Gee JM. Agrawal A, et al. Among authors: nicholson ri. Int J Cancer. 2016 Jan 1;138(1):146-59. doi: 10.1002/ijc.29682. Epub 2015 Jul 30. Int J Cancer. 2016. PMID: 26178788 Free PMC article.

5

c-erbB-2 oncoprotein expression in primary and advanced breast cancer.

Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R, Gullick WJ, Elston CW, Blamey RW. Lovekin C, et al. Br J Cancer. 1991 Mar;63(3):439-43. doi: 10.1038/bjc.1991.101. Br J Cancer. 1991. PMID: 1672254 Free PMC article.

6

Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: associations with other prognostic factors and survival.

Pinder SE, Wencyk P, Sibbering DM, Bell JA, Elston CW, Nicholson R, Robertson JF, Blamey RW, Ellis IO. Pinder SE, et al. Br J Cancer. 1995 Jan;71(1):146-9. doi: 10.1038/bjc.1995.30. Br J Cancer. 1995. PMID: 7819031 Free PMC article.

7

Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer.

Kenny FS, Willsher PC, Gee JM, Nicholson R, Pinder SE, Ellis IO, Robertson JF. Kenny FS, et al. Breast Cancer Res Treat. 2001 Jan;65(2):135-44. doi: 10.1023/a:1006469627067. Breast Cancer Res Treat. 2001. PMID: 11261829

8

Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy.

Robertson JF, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW. Robertson JF, et al. Among authors: nicholson ri. Breast Cancer Res Treat. 1992;22(3):221-7. doi: 10.1007/BF01840835. Breast Cancer Res Treat. 1992. PMID: 1391988

9

Comparison of two oestrogen receptor assays in the prediction of the clinical course of patients with advanced breast cancer.

Robertson JF, Bates K, Pearson D, Blamey RW, Nicholson RI. Robertson JF, et al. Among authors: nicholson ri. Br J Cancer. 1992 May;65(5):727-30. doi: 10.1038/bjc.1992.153. Br J Cancer. 1992. PMID: 1534019 Free PMC article.

10

Cellular effects of tamoxifen in primary breast cancer.

Robertson JF, Ellis IO, Nicholson RI, Robins A, Bell J, Blamey RW. Robertson JF, et al. Among authors: nicholson ri. Breast Cancer Res Treat. 1992 Jan;20(2):117-23. doi: 10.1007/BF01834641. Breast Cancer Res Treat. 1992. PMID: 1554887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters